New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Updated September 17th, 2020

New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Guidelines recommend PARP inhibitors for a wider group of women; this is based on recent studies that found these drugs improve survival rates.

NOW
PLAYING
Kayleigh McEnany: Fear of Dating Post-Mastectomy Delayed Breast Cancer Surgery
NOW
PLAYING
Actor Pierce Brosnan, 68, Celebrates Love For His Wife-- Years After Tragic Loss-- The Remarkable Progress In Ovarian Cancer
NOW
PLAYING
Breast Cancer Survivor and Journalist Susan Berger Says Reporting on the PALB2 Mutation May Have Saved Her Life
NOW
PLAYING
12-Year-Old With Stomach Pains Learns She Has Ovarian Cancer
NOW
PLAYING
New Hope for Patients With Cervical Cancer: Adding Immunotherapy Drug to Standard Chemo Treatment Could Improve Survival Time
NOW
PLAYING
Sherry Pollex Promotes Ovarian Cancer Awareness at NASCAR Race
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.